[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.166.48.3. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
October 7, 2009

Lactoferrin Supplementation to Prevent Nosocomial Infections in Preterm Infants

Author Affiliations

Author Affiliations: Division of Neonatology, Department of Pediatrics, University of Virginia Health System, Charlottesville.

JAMA. 2009;302(13):1467-1468. doi:10.1001/jama.2009.1449

The study by Manzoni and colleagues1 in this issue of JAMA represents an important step toward preventing infections that currently pose a major hurdle for preterm infants. The findings give insight into the role of lactoferrin in preventing infection, helping to define its importance in breast milk as well as the effect of daily supplementation with bovine lactoferrin (BLF) in preterm infants.

First Page Preview View Large
First page PDF preview
First page PDF preview
×